AstraZeneca
rare disease | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
November 2021
Slide
29 of 39
Related slides by other companies
Equillium
Investor Presentation
August 2023
opportunity celiac disease has no approved therapies celiac disease billion dollar annual market opportunity me | Equillium
Equillium
Investor Presentation
February 2024
no approved therapies for celiac disease celiac disease billion dollar annual market opportunity me | Equillium
AbCellera
Results
August 2023
end market is antibody medicines | AbCellera
Lifeline SPAC 1
Results
August 2023
lifeline i rare opportunity to invest in high growth tech at an attractive risk return inflection point | Lifeline SPAC 1
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io